These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11912164

  • 1. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.
    Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA.
    Cancer Res; 2002 Mar 15; 62(6):1847-53. PubMed ID: 11912164
    [Abstract] [Full Text] [Related]

  • 2. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K.
    Cancer Res; 2005 Mar 15; 65(6):2387-96. PubMed ID: 15781654
    [Abstract] [Full Text] [Related]

  • 3. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J, Rabbani SA, Shibata HR, Brodt P.
    J Clin Invest; 1995 May 15; 95(5):2096-103. PubMed ID: 7537755
    [Abstract] [Full Text] [Related]

  • 4. Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor.
    Rofstad EK, Mathiesen B, Galappathi K.
    Cancer Res; 2004 Jan 01; 64(1):13-8. PubMed ID: 14729600
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts.
    Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, Nilsen K, Galappathi K.
    Cancer Res; 2002 Feb 01; 62(3):661-4. PubMed ID: 11830516
    [Abstract] [Full Text] [Related]

  • 6. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH, Wang C, Zhang YH, Yang YH, Zhan HY, Zhang LM.
    Zhonghua Yi Xue Za Zhi; 2007 Dec 04; 87(45):3228-32. PubMed ID: 18399120
    [Abstract] [Full Text] [Related]

  • 7. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis.
    Rofstad EK, Galappathi K, Mathiesen B, Ruud EB.
    Clin Cancer Res; 2007 Apr 01; 13(7):1971-8. PubMed ID: 17360973
    [Abstract] [Full Text] [Related]

  • 8. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 9. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 10. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD, Tomaso H, Mengele K, Schilling D, Bayer C, Stadler P, Schmitt M, Molls M.
    Oncol Rep; 2007 May 15; 17(5):1259-68. PubMed ID: 17390074
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R, Berking C, Kammerbauer C, Degitz K.
    Cell Death Differ; 2007 Apr 15; 14(4):818-29. PubMed ID: 17110957
    [Abstract] [Full Text] [Related]

  • 12. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H, Sato H, Shirai S, Kobayashi S, Fukumoto K, Ishida T, Seki T, Ariga T, Yano T.
    Life Sci; 2006 Apr 04; 78(19):2249-54. PubMed ID: 16289236
    [Abstract] [Full Text] [Related]

  • 13. Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia.
    Maity A, Solomon D.
    Exp Cell Res; 2000 Mar 15; 255(2):250-7. PubMed ID: 10694440
    [Abstract] [Full Text] [Related]

  • 14. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.
    Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576
    [Abstract] [Full Text] [Related]

  • 15. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.
    Yoon SY, Lee YJ, Seo JH, Sung HJ, Park KH, Choi IK, Kim SJ, Oh SC, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    Cell Res; 2006 Jan 10; 16(1):75-81. PubMed ID: 16467878
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 17. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Cancer Res; 2003 May 15; 63(10):2454-61. PubMed ID: 12750266
    [Abstract] [Full Text] [Related]

  • 18. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry.
    Gulliksrud K, Vestvik IK, Galappathi K, Mathiesen B, Rofstad EK.
    Radiat Res; 2008 Nov 15; 170(5):638-50. PubMed ID: 18959463
    [Abstract] [Full Text] [Related]

  • 19. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, O'Brien PM, Li Y.
    Gynecol Oncol; 2009 Aug 15; 114(2):265-72. PubMed ID: 19450871
    [Abstract] [Full Text] [Related]

  • 20. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q, Liang LJ, Peng BG, Zhen YY.
    Ai Zheng; 2006 Nov 15; 25(11):1433-8. PubMed ID: 17094916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.